Menopause
Current BC and Canadian guidelines, algorithms, tools, prescribing references and patient resources for nurse practitioners.
Reviewed by Joe Grafe Due
Review overdue
This page was due for review on November 6, 2027. Check the linked sources for newer versions before relying on it.
Key Sources¶
BC Provincial Academic Detailing - Medications for Menopause-Associated Vasomotor and Genitourinary Symptoms (2026)
BC Ministry of Health pharmacist-led education on oral, transdermal and vaginal estrogens and progestogens, fezolinetant and transdermal testosterone. There is no BC Guideline on menopause.
- BC Provincial Academic Detailing - Medications for Menopause-Associated Vasomotor and Genitourinary Symptoms (2026) · PDF — 12-page evidence summary for vasomotor and genitourinary symptoms
- Drug Table (PDF, March 2026) — products, strengths, monthly cost and PharmaCare benefit status
- Transdermal Testosterone Supplement (PDF, March 2026) · PAD Refill: Transdermal Testosterone for HSDD (PDF, May 2026) — hypoactive sexual desire disorder
- Reference List (PDF, March 2026)
- Book a session: e-mail PAD@gov.bc.ca
- Centre for Effective Practice - Menopause Management (2025) · PDF — Ontario primary care tool from perimenopause to postmenopause: menopausal hormone therapy risk assessment and shared decisions.
SOGC - Menopause Clinical Practice Guideline No. 422, seven chapters (2021)
Society of Obstetricians and Gynaecologists of Canada, with the Canadian Menopause Society. Open access in JOGC; replaced the 2014 Managing Menopause guideline. No newer SOGC menopause guideline as of November 2026.
- SOGC Menopause Care Continuum Interactive Tool — point-of-care prompts by menopause stage for assessment, investigations and referral, each linked to its chapter
- Guideline No. 422a: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle (2021) · PDF · Corrigendum (2022) — hot flashes and night sweats: hormone, non-hormonal and lifestyle options
- Guideline No. 422b: Menopause and Genitourinary Health (2021) · PDF — vaginal dryness, dyspareunia, overactive bladder and recurrent UTI
- Guideline No. 422c: Mood, Sleep, and Cognition (2021) · PDF
- Guideline No. 422d: Menopause and Sexuality (2021) · PDF — low desire and painful intercourse
- Guideline No. 422e: Menopause and Cardiovascular Disease (2021) · PDF
- Guideline No. 422f: Menopause and Breast Cancer (2021) · PDF — menopause care for breast cancer survivors and hereditary breast and ovarian cancer carriers
- Guideline No. 422g: Menopause and Osteoporosis (2022) · PDF
- CMAJ - A Pragmatic Approach to the Management of Menopause (2023) · PDF — Lega IC, et al. CMAJ 2023;195(19):E677. Canadian review for primary care; open access.
Further Resources¶
- BC Provincial Academic Detailing - Medications for Menopause-Associated Vasomotor and Genitourinary Symptoms (2026) · PDF — BC Ministry of Health pharmacist-led education on oral, transdermal and vaginal estrogens and progestogens, fezolinetant and transdermal testosterone. There is no BC Guideline on menopause.
Ontario Health quality standard - Menopause: Care for Women and Gender-Diverse People (2025)
Canada's first menopause quality standard (Ontario): six quality statements on identifying, assessing and managing symptoms.
BC Women's Hospital - Menopause Resources for Health Professionals
BC Women's Hospital + Health Centre (PHSA): tools, recorded webinars and printable guides
- Menopause Management for the Rural Physician (UBC CPD Rural Rounds slides, PDF, January 2025) — Dr. Kelsey Mills, BC Women's Hospital
- Webinar - Genitourinary Syndrome of Menopause: What Is It? What Do I Need to Know? — Dr. Kelsey Mills
- Webinar - Testosterone and Menopause: Cutting Through the Noise
- Webinar - Hard Facts About Soft Bones: Menopause and Bone Health
- Therapeutics Initiative webinar - Evidence-Based Approaches to Menopause: Overcoming Misinformation (2026) · PDF — UBC Therapeutics Initiative Best Evidence webinar by Dr. Iliana Lega, with slides
BC Medical Journal - Managing Menopause: two-part review of the 2021 SOGC guideline
BCMJ 2022;64(8).
Canadian Menopause Society - Publications for Professionals
National menopause society, co-publisher of the SOGC Menopause Hub.
- Menopause Pocket Guide (PDF, 2023 revised) — printable guide to menopause management
- Menopause Hub for Professionals
Centre for Effective Practice - Menopause Management (2025)
Ontario primary care tool from perimenopause to postmenopause: menopausal hormone therapy risk assessment and shared decisions.
Canadian Family Physician and CMAJ articles
- CMAJ: Perimenopause (2024) — Lega IC, Jacobson M. CMAJ 2024;196(34):E1169.
- CFP: How to Help Patients Navigate Genitourinary Syndrome of Menopause (2024) — by RxFiles academic detailing pharmacists and a Saskatoon menopause clinic physician
- CMAJ: Urinary Tract Infections After Menopause (2025)
- CMAJ: Menopausal Hormone Therapy in Patients With a History of Gynecologic Cancer (2023)
- CFP: Recognizing Ethnic and Cultural Variation in Menopause Care (2026)
International: AAFP - Managing Menopausal Symptoms: Common Questions and Answers (2023)
International source: American review, not Canadian. American Family Physician 2023;108(1):28-39, free to read; updated online for fezolinetant.
- Article (PDF)
- Editorial - Menopause Management: When Hormone Therapy Is Appropriate (2026)
- Editorial - Menopausal Hormone Therapy: Limited Benefits, Significant Harms (2025) — paired with the editorial above; the two give opposing views
International: International Menopause Society (IMS) Recommendations on Women's Midlife Health and Menopause (2025)
International source: global society guideline, not Canadian. GRADE-rated recommendations from lifestyle and vasomotor symptoms to POI, osteoporosis and cancer.
- Recommendations and Key Messages (Climacteric, 2025) — Panay N, et al. Climacteric 2025;28(6):634-656.
International: The Menopause Society - Position Statements
International source: North American (US-based) society, not Canadian. Each statement has a patient handout (MenoNote).
International: NICE - Menopause: Identification and Management (NG23) (2026)
International source: UK guidance, not Canadian. Published 2015, last updated April 15, 2026.
- Identifying Perimenopause and Menopause
- Diagnosing and Managing Premature Ovarian Insufficiency (under 40)
- Starting and Stopping Hormone Replacement Therapy
- Discussion Aid: Incidence of Medical Conditions With and Without HRT (PDF) — absolute risks for shared decisions
- Visual Summary: Genitourinary Symptoms Associated With Menopause (PDF)
- Full Guideline (PDF)
Algorithms and Pathways¶
- Pathways BC - Provincial Menopause and Perimenopause Primary Care Clinical Pathway (2026) — 48-page BC pathway adapted from Alberta's: history and assessment, vasomotor and genitourinary symptoms, MHT medication tables, referral criteria, clinician tools and patient information
- Pathways BC - Post-Menopausal Bleeding Primary Care Pathway (2026) — red flag: history, investigations, referral and bleeding on MHT
- MQ6 Treatment Algorithm (interactive) (2025) · Printable algorithm (image) — Canadian decision tool that follows the MQ6 assessment; first published in Canadian Family Physician, 2017
Alberta's Menopause and Perimenopause pathway was updated in January 2026 and its Post-Menopausal Bleeding pathway is under scheduled review (the hub's New & upcoming list, checked November 6, 2026). The BC pathways above are adapted from them.
Assessment Tools and Calculators¶
- BC Guidelines: CVD Primary Prevention Appendix B - Framingham 10-year Risk Estimation (2021) · PDF — part of the BC menopause pathway's assessment step
- MQ6 Menopause Assessment Tool · Fillable version — six-question Canadian screen for menopausal symptoms, developed by a family physician; patients can complete it before the visit
- Choosing Wisely Canada - Obstetrics and Gynaecology Recommendations (SOGC) (2021) — includes hormone level testing (FSH, estradiol) after menopause or hysterectomy
- FRAX Fracture Risk Assessment Tool (Canada) — 10-year fracture risk with or without BMD; Canadian version
Prescribing¶
- BC PharmaCare: Plan NP Menopausal Hormone Therapy (2026) — covered estrogen and progestogen products by DIN, full or partial benefit, since March 1, 2026; no Special Authority needed
- BC PharmaCare Formulary Search — check coverage of a drug not on the Plan NP list
RxFiles - Menopause (2025)
RxFiles (University of Saskatchewan) guide to menopause management in primary care. The documents need an RxFiles subscription.
- Canadian Menopause Society - MHT Tables (2025) · PDF — menopausal hormone therapy products available in Canada, tables 1 to 7
- Canadian Menopause Society - Systemic MHT Equivalency Table (2025) · PDF — equivalent doses across systemic estrogen products
Non-hormonal drugs for vasomotor symptoms: evidence summaries
- Tools for Practice #399: Turn Down the Heat, Part II! Can fezolinetant improve vasomotor symptoms in menopause? (2025) · PDF
- Tools for Practice #353: Turn Down the Heat! Can non-hormonal drugs improve vasomotor symptoms in menopause? (2023) · PDF — SSRIs, SNRIs, gabapentin and others
- CMAJ: Neurokinin-3 Receptor Antagonists for Vasomotor Symptoms in Menopause and Breast Cancer Survivorship (2026)
Advice and Referral¶
- RACE - Rapid Access to Consultative Expertise — telephone and app advice from BC specialists for family physicians, nurse practitioners and midwives
- Pathways BC - Obstetrics / Gynecology — login; specialists and clinics, with referral details
- Ontario eConsult (OTNhub) — specialist advice for Ontario physicians and nurse practitioners, usually without a patient referral
BC Women's Hospital - Complex Menopause Clinic Referral
Provincial clinic, virtual and in person, for severe or complex menopause; eligibility and exclusion criteria are on the page. Referral from a physician or nurse practitioner.
- Referral Form (PDF) — fax 604-675-2652
- BC Women's Hospital - After Breast Cancer Clinic — nurse practitioner-led transitional care for people on adjuvant endocrine therapy after breast cancer
Patient Resources¶
- HealthLink BC - Menopause and Perimenopause
- HealthLink BC - Menopause: Should I Use Hormone Therapy (HT)? — decision aid
- HealthLink BC - Menopause: Managing Hot Flashes
- HealthLink BC - Vaginal Dryness
- BC PharmaCare - National Pharmacare (Plan NP) for BC Residents — coverage of menopausal hormone therapy since March 1, 2026
- BC Women's Hospital - Menopause · Menopause Hot Topics Webinars
- Menopause and U (SOGC) — symptoms, hormone and non-hormonal therapy, and pages for gender-diverse, Black and Indigenous communities
- Menopause Foundation of Canada - Resources · Before You Go to Your Health Care Practitioner
- Canadian Menopause Society - For Women
- Heart & Stroke - Menopause — menopause and heart health
- Health Canada - Safe Use of Natural Health Products for Menopause
Also known as: perimenopause, menopausal symptoms, postmenopause, climacteric, change of life, hot flashes, hot flushes, vasomotor symptoms, VMS, genitourinary syndrome of menopause, GSM, vaginal atrophy, vulvovaginal atrophy, atrophic vaginitis, vaginal dryness, HRT, MHT, hormone replacement therapy, menopausal hormone therapy, estradiol, micronized progesterone, Prometrium, Estrogel, Divigel, Estradot, Premarin, Vagifem, Imvexxy, fezolinetant, Veozah, premature ovarian insufficiency, POI, early menopause, surgical menopause, postmenopausal bleeding